Assignee
ARRAY BIOPHARMA INC
US·217 granted patents·73 pending applications·2,267 citations·filing 1998–2025
Top patents by PatentIndex Score
290 records- 0199US9676783B2Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Jun 13, 2017·23 cites·83 claims
- 0299US9127013B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Sep 8, 2015·47 cites·30 claims
- 0399US8865698B2Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 21, 2014·45 cites·33 claims
- 0498US10174028B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·14 cites·29 claims
- 0598US10174027B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jan 8, 2019·17 cites·30 claims
- 0698US10138243B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·14 cites·29 claims
- 0798US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0898US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0998US9447104B2Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2014·Granted Sep 20, 2016·21 cites·92 claims
- 1097US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 1197US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 1297US10047097B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 14, 2018·9 cites·22 claims
- 1397US10023570B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 17, 2018·14 cites·103 claims
- 1497US10005783B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 26, 2018·10 cites·140 claims
- 1597US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 1697US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 1797US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 1897US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 1996US10208024B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·32 cites·27 claims
- 2096US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 2196US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 2296US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 2396US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 2496US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 2596US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 2696US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 2796US7425637B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2005·Granted Sep 16, 2008·27 cites·1 claims
- 2895US9796723B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·15 cites·30 claims
- 2995US9795611B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·15 cites·30 claims
- 3095US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 3195US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 3295US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 3395US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 3494US11414404B2Compounds for the treatment of BRAF-associated diseases and disordersARRAY BIOPHARMA INC·Filed 2020·Granted Aug 16, 2022·5 cites·14 claims
- 3594US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 3694US9782414B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·22 cites·30 claims
- 3794US7777050B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 17, 2010·13 cites·9 claims
- 3894US7169926B1Dipeptidyl peptidase inhibitorsARRAY BIOPHARMA INC·Filed 2004·Granted Jan 30, 2007·68 cites·72 claims
- 3993US10780073B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·7 cites·24 claims
- 4093US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 4193US10172861B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·15 cites·18 claims
- 4293US10143692B2Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2018·Granted Dec 4, 2018·7 cites·36 claims
- 4393US10011604B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Jul 3, 2018·9 cites·18 claims
- 4493US9889134B2Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2015·Granted Feb 13, 2018·8 cites·16 claims
- 4593US9168254B2Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2012·Granted Oct 27, 2015·15 cites·127 claims
- 4693US8697715B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 15, 2014·21 cites·25 claims
- 4793US7235537B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 26, 2007·53 cites·10 claims
- 4892US10584124B2Crystalline formsARRAY BIOPHARMA INC·Filed 2018·Granted Mar 10, 2020·12 cites·9 claims
- 4992US9850230B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·7 cites·9 claims
- 5092US9593100B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·25 claims
Showing the top 50 of 290 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARRAY BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →